ITGB3 and atherosclerosis: In addition, we identified ITGB3 as a direct target of miR-351-5p. In diabetic patients, miR-351 promotes atherosclerosis by targeting ITGB3 and inhibits the PIK3R1/Akt pathway, upregulating endothelial cell apoptosis.